EurekAlert!24 天
New genetic mutation linked to drug resistance in non-small cell lung cancer patient
who acquired resistance to lorlatinib after 6 months on therapy through a novel RUFY1-RET fusion, detected..." “Here we present a case of a patient with stage IV CD-74-ROS1 fusion NSCLC ...